Once-Daily Opicapone Increases ON-Time in Patients with Parkinson’s Disease: Results from Two Randomized, Double-Blind, Placebo-Controlled Phase 3 Studies

Need to get in touch with us?

medinfo@neurocrine.com
1-877-641-3461